JPH0262890A - Polyacetyloligosaccharide derivative - Google Patents

Polyacetyloligosaccharide derivative

Info

Publication number
JPH0262890A
JPH0262890A JP21452088A JP21452088A JPH0262890A JP H0262890 A JPH0262890 A JP H0262890A JP 21452088 A JP21452088 A JP 21452088A JP 21452088 A JP21452088 A JP 21452088A JP H0262890 A JPH0262890 A JP H0262890A
Authority
JP
Japan
Prior art keywords
formula
added
alpha
compound expressed
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP21452088A
Other languages
Japanese (ja)
Other versions
JPH0692432B2 (en
Inventor
Mitsunori Ono
光則 小野
Nobuo Suzuki
信雄 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP21452088A priority Critical patent/JPH0692432B2/en
Publication of JPH0262890A publication Critical patent/JPH0262890A/en
Publication of JPH0692432B2 publication Critical patent/JPH0692432B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

NEW MATERIAL:A compound expressed by formula I (n is 0-9; Ac is formula II; R and R' are H, alkyl or phenyl). USE:A precursor of substrates for measuring enzymic activity. PREPARATION:A compound expressed by formula III, together with alpha,alpha- dimethoxytoluene, p-toluenesulfonic acid and dimethylformamide, is stirred at 50-60 deg.C under reduced pressure for 4hr and then cooled to ambient temperature. Pyridine, acetic anhydride and dimethylaminiopyridine are added and the resultant mixture is allowed to stand for 20hr, extracted with ethyl acetate and purified by silica gel chromatography. Furthermore, the reaction mixture is dissolved in methanol and 10% palladium carbon is added to carry out reaction under normal pressure in a hydrogen atmosphere for 6hr. After filtration, recrystallization from ethanol is performed to afford the objective derivative.

Description

【発明の詳細な説明】 (発明の分野) 本発明は、酵素活性測定用基質のための前駆体として有
用な、非還元末端糖の≠、を位が保換され、還元末端に
p−アミノフェニルグルコシド結合tMしたポリアセチ
ルオリゴ糖誘導体に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of the Invention) The present invention relates to a non-reducing end sugar that is useful as a precursor for a substrate for measuring enzyme activity, in which the ≠ position is conserved, and p-amino at the reducing end. The present invention relates to a polyacetyl oligosaccharide derivative with phenyl glucoside bonds.

(従来の技術) 非還元末端糖の≠、6位のみが水酸基の1まで他の水酸
基が保護されたオリゴ糖誘導体は、IJ−ビツヒ アナ
レン デエア ケミ−(LibigsAnnalen 
 der  Chemie )/りr3、/り/θ〜/
り/夕に記載されている。この文献においては、還元末
端がフェニルグリコシド結合となっている。
(Prior art) Oligosaccharide derivatives in which ≠ and other hydroxyl groups are protected at only the 6th position of the non-reducing terminal sugar are IJ-Annalen Deer Chemie (LibigsAnnalen Deer Chemie).
der Chemie )/ri r3,/ri/θ~/
It is written in the evening. In this document, the reducing end is a phenyl glycoside bond.

又、非還元末端糖の≠、6位の水酸基を他の水酸基と区
別し、還元末端かに一アミノフェニルグリコシド結合金
有したオリゴ糖誘導体は特開昭60−j≠3りj1特開
昭1.0−47227、特開昭A/−431タタに記載
されている。こnらの公報においては、非還元末端糖の
≠、乙位の水酸基だけしか保護されていない。
In addition, the hydroxyl group at the ≠ and 6-position of the non-reducing end sugar is distinguished from other hydroxyl groups, and oligosaccharide derivatives having a monoaminophenyl glycoside bond at the reducing end are disclosed in JP-A-60-J≠3-J1. 1.0-47227, and is described in Japanese Patent Application Laid-open No. 1999-431 Tata. In these publications, only the hydroxyl groups at the ≠ and B positions of the non-reducing terminal sugar are protected.

いずれの場合も非還元末端部分音さらに官能基で修飾す
るために弘、6位の非還元末端位と他の水酸基を別々の
形で保護し7′cp−アミノフェニルグルコシド結合全
市したポリアセチルオリゴ糖誘導体に関しては、1つた
く記載がない。
In both cases, in order to modify the non-reducing terminal partial with a functional group, the non-reducing terminal position at the 6-position and other hydroxyl groups were protected separately, and the polyacetyl oligomer was bonded with a 7'cp-aminophenyl glucoside bond. Regarding sugar derivatives, there is no mention at all.

(発明の目的) 本発明の目的は非還元末端抛の≠、乙位が保護され、還
元末端にp−アミノフェニルグリコシド結合を有するポ
リアセチルオリゴ糖誘導体を提供することにある。
(Object of the Invention) The object of the present invention is to provide a polyacetyl oligosaccharide derivative in which the ≠ and ≠ positions of the non-reducing end are protected and have a p-aminophenyl glycosidic bond at the reducing end.

(発明の構成) い。(Structure of the invention) stomach.

以下に本発明の好ましい具体例を物性値と共に列接する
Preferred specific examples of the present invention are listed below along with physical property values.

(/] 式中nはO〜りの整数を表わし、Acは−CCHs基を
表わす。R%l(1は水素原子、アルキル基、フェニル
基を表わす。nは好ましくはn=/、コ、≠、!である
。JRIのアルキル基としてはメチル基が好ましい。R
,R’としては片方が水素原子で他方がメチル基または
フェニル基の場合、及び両方がメチル基の場合が好1し
本発明の化合物を合成するための経路の一例を次に示す
が、 本発明の化合物の合成方法はこの経 路に限定されるものではない。
(/] In the formula, n represents an integer from O to 2, and Ac represents a -CCHs group. R%l (1 represents a hydrogen atom, an alkyl group, or a phenyl group. n is preferably n=/, co, ≠,!.The alkyl group of JRI is preferably a methyl group.R
, R' is preferably a hydrogen atom and the other is a methyl group or a phenyl group, or both are methyl groups. An example of the route for synthesizing the compound of the present invention is shown below. The method of synthesizing the compounds of the invention is not limited to this route.

(市販品) 〕2 ニージメ トキシトルエン、 p−)ルエンスルホン酸 一ルホルムアミ ド 5ン、無水酢酸、ジメチルアミノピリジン;パラジウム
炭素、 メタノール、 水素 (発明の効果) 本発明の化合物〔l〕の脱アセチル体は、特定の酵素に
より’、≠のグリコシド結合が切断される基質である。
(Commercially available product) 2 dimethoxytoluene, p-)luenesulfonic acid monolformamide, acetic anhydride, dimethylaminopyridine; palladium on carbon, methanol, hydrogen (effects of the invention) Deacetylation of the compound [l] of the present invention The body is a substrate whose glycosidic bond is cleaved by a specific enzyme.

この際、非還元末端糖のび位、6位の水酸基の両方もし
くは一方に機能性化合物、例えばバイオアフィニティー
をもったものを結合させることで酵素で切断された非還
元末端部分と、p−アミノフェニルグリコシド結合を有
す糖部分とをバイオアフィニティーを利用して分けるこ
とができる。
At this time, a functional compound, such as one with bioaffinity, is bonded to both or one of the hydroxyl group at the 6-position and the non-reducing end sugar position, and the non-reducing end portion is enzymatically cleaved and p-aminophenyl. Sugar moieties with glycosidic bonds can be separated using bioaffinity.

即ち、同−m液内に過剰の基質が存在しても酵素の量に
応じ、酵素によ、って切断された生成物の中でp−アミ
ノフェニルグリコシド結合t[−した糖部分だけを分離
できることになる。分離されたp−アミノフェニルグリ
コシド結合ヲ有した糖部分は、更に酵素で処理すればp
−アミンフェノールだけが遊離する。このp−アミノフ
ェノール誘導体することで酵素の定量ができることにな
る(なおp−アミンフェノールの定量法としては、ジャ
ーナル バイオロジカル ケミストリー(Journa
lBiological  Chemistry  )
A 7、lO(/9j7)などに記載されているニンヒ
ドリン法などが知られている)。
In other words, even if there is an excess of substrate in the same solution, only the sugar moiety with the p-aminophenyl glycoside bond t[- is removed in the product cleaved by the enzyme, depending on the amount of the enzyme. It will be possible to separate. The separated sugar moiety with a p-aminophenyl glycoside bond can be further treated with an enzyme to form a p-aminophenyl glycoside bond.
-Only the amine phenol is liberated. Enzymes can be quantified by using this p-aminophenol derivative (a method for quantifying p-aminophenol is described in the Journal Biological Chemistry).
lBiological Chemistry)
The ninhydrin method described in A7, IO(/9j7), etc. is known).

又、アミノ基に高感度な色素や螢光物質や写真化学的造
核剤を結合させれば、微葉のp−アミノフェノール誘導
体が測定できることになる。
Furthermore, if a highly sensitive dye, fluorescent substance, or photochemical nucleating agent is bonded to the amino group, p-aminophenol derivatives in microphytes can be measured.

よって本発明の化合物は高感度な酵素検出法の基質の前
駆体としても大変有用である。
Therefore, the compounds of the present invention are also very useful as substrate precursors for highly sensitive enzyme detection methods.

実施例1−数式(1)の化合物人−≠の合成人)非還元
末端糖の≠、6位の選択的保護法≠−ニトロフェニル−
α−D−マルトヘプタオシドジメチルホルムアミド ジメチルホルムアミド(D)iF)λ00rnt中にα
、α−ジメトキシトルエンJ、jrが(/、jeq)、
k−トルエンスルホン酸sa弘Fn9(o、/eq)、
≠−ニトロフェニルーα−D−vルトヘゾタオシド(市
販品) (G7−PNP )20 ?kml14させ、
減圧(約20111H?)下jO°C〜40”Cにて≠
時間攪拌した。
Example 1 - Synthesis of the compound of formula (1) -≠) Selective protection method for the ≠, 6-position of the non-reducing terminal sugar≠-nitrophenyl-
α-D-maltoheptaoside dimethylformamide dimethylformamide (D) iF) α in λ00rnt
, α-dimethoxytoluene J, jr (/, jeq),
k-toluenesulfonic acid sahiro Fn9 (o, /eq),
≠-Nitrophenyl α-D-v rutohesotaoside (commercial product) (G7-PNP) 20? kml14,
Under reduced pressure (approximately 20111H?) at 0°C to 40"C≠
Stir for hours.

反応液を室温まで冷却し、ピリジン700m!、無水酢
酸lλOml、ジメチルアミノピリジンj00〜を加え
室温にて20時間放置した。
The reaction solution was cooled to room temperature, and 700 m! of pyridine was added. , lλOml of acetic anhydride, and dimethylaminopyridine j00~ were added, and the mixture was left at room temperature for 20 hours.

反応液を氷水rooryttに圧加し、酢酸エチル!o
occにて2回抽出した。有機IIを飽和炭酸水素ナト
リウム水rOqmtにて2回、水r00rttlにて1
回洗浄後硫酸ナトリウムにて乾燥した。硫酸ナトリウム
を口別して除去し、口液を減圧濃縮し、淡黄色の無定形
固体物を得た。
The reaction solution was pressurized into ice water and ethyl acetate! o
Extracted twice with occ. Organic II was dissolved twice in saturated sodium bicarbonate water rOqmt and once in water r00rttl.
After washing twice, it was dried with sodium sulfate. The sodium sulfate was removed by portion, and the oral liquid was concentrated under reduced pressure to obtain a pale yellow amorphous solid.

この反応混合物をシリカゲルカラムクロマトグラフィー
(耐離液ヘキサン/酢酸エチル=//2(v/vl) 
 にて精製し、化合物■全白色粉末としてA−!−■2
0 r (G7−PNP  カらの収率!t%)を得た
This reaction mixture was subjected to silica gel column chromatography (separating liquid: hexane/ethyl acetate=//2 (v/vl)).
The compound ■A-! was purified as a completely white powder. −■2
0 r (yield from G7-PNP! t%) was obtained.

以下に物性値を示す。The physical property values are shown below.

m、p、    / II / 〜/ 4tj ’C(
α〕   +/7/   (CHQ!s、0.91)F
AB−MS  2.2λAm/e [M+N a 〕”
B)ニトロ基の還元 A−≠−■ 化合物A−≠−■0.32をメタノール−0rtdに浴
解し、よ%パラジウムー炭素0.OJfを加え、水素雰
囲気下常圧1時間反応させた。
m, p, / II / ~ / 4tj 'C (
α] +/7/ (CHQ!s, 0.91)F
AB-MS 2.2λAm/e [M+N a ]”
B) Reduction of nitro group A-≠-■ Compound A-≠-■ 0.32% was dissolved in methanol-0rtd, and 0% palladium-carbon was dissolved. OJf was added, and the mixture was reacted for 1 hour at normal pressure under a hydrogen atmosphere.

不溶性固体をセライトを用いて口過にて除去しメタノー
ルにて洗浄し、口液を集めて減圧濃縮した。
Insoluble solids were removed by filtration using Celite, washed with methanol, and the oral liquid was collected and concentrated under reduced pressure.

得られた固体をエタノールにて再結晶し、目的の化合物
A−≠を白色結晶として0.JP(定電的)得た。
The obtained solid was recrystallized from ethanol, and the target compound A-≠ was converted into white crystals with a 0.0. JP (static) was obtained.

以下に物性値を示す。The physical property values are shown below.

m、p、  ;  /jコ〜/It °C(α〕D、 
 + / tl !  (CHCJa、O6りよ)FA
B−MS  ;  2r/タ (M+N a )”20
0MHz−FINMR(爵媒CDCta、標準物質TM
S)δ;2.Oコ〜2.2弘 (CCHa、s140M
)7、/2〜7.2タ (0−CsH+−(k−NHz
)、邑弘H) 実施例λ 実施例1K記載の方法に準じて、出発物質をそレソtt
 p−ニトロフェニル−α−D−マルトシド、p−ニト
ロフェニル−α−D−マルトトリオシト、p−二)oフ
ェニル−α−D−マルトハンタオシドに変更することに
よって(1=/、n=コ、n=3である一般式〔l〕の
化合物A−/1A−2、A−J1&:合成した。物性値
は前述の通りである。
m, p, ; /jko~/It °C(α]D,
+/tl! (CHCJa, O6 Riyo) FA
B-MS; 2r/ta (M+N a )”20
0MHz-FINMR (medium CDCta, standard material TM
S) δ;2. Oko ~ 2.2 Hiro (CCHa, s140M
)7, /2~7.2ta (0-CsH+-(k-NHz
), Hiromu H) Example λ The starting materials were prepared according to the method described in Example 1K.
By changing to p-nitrophenyl-α-D-maltoside, p-nitrophenyl-α-D-maltotriosito, p-di)o-phenyl-α-D-maltohantaoside (1=/, n Compounds A-/1A-2 and A-J1& of the general formula [l] where = co, n = 3 were synthesized.The physical properties are as described above.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の化合物を合成するのに用いた化合物人
−≠−[相])の赤外吸収スペクトル(KBr法)のグ
ラフである。 特許出願人 富士写真フィルム株式会社4、補正の対象
  明細書の「発明の詳細な説明」の慎
FIG. 1 is a graph of the infrared absorption spectrum (KBr method) of the compound (-≠-[phase]) used to synthesize the compound of the present invention. Patent applicant Fuji Photo Film Co., Ltd.4, subject of amendment

Claims (1)

【特許請求の範囲】 式〔1〕で表わされるポリアセチルオリゴ糖誘導体 ▲数式、化学式、表等があります▼〔1〕 式中nは0〜9の整数を表わし、Acは ▲数式、化学式、表等があります▼基を表わす。R、R
^1は水素原子、アルキル基またはフェニル基を表わす
[Claims] Polyacetyl oligosaccharide derivative represented by formula [1] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [1] In the formula, n represents an integer from 0 to 9, and Ac represents ▲ mathematical formula, chemical formula, There are tables, etc. ▼ Represents a group. R, R
^1 represents a hydrogen atom, an alkyl group or a phenyl group.
JP21452088A 1988-08-29 1988-08-29 Polyacetyl oligosaccharide derivative Expired - Fee Related JPH0692432B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21452088A JPH0692432B2 (en) 1988-08-29 1988-08-29 Polyacetyl oligosaccharide derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21452088A JPH0692432B2 (en) 1988-08-29 1988-08-29 Polyacetyl oligosaccharide derivative

Publications (2)

Publication Number Publication Date
JPH0262890A true JPH0262890A (en) 1990-03-02
JPH0692432B2 JPH0692432B2 (en) 1994-11-16

Family

ID=16657083

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21452088A Expired - Fee Related JPH0692432B2 (en) 1988-08-29 1988-08-29 Polyacetyl oligosaccharide derivative

Country Status (1)

Country Link
JP (1) JPH0692432B2 (en)

Also Published As

Publication number Publication date
JPH0692432B2 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
FR2470774A1 (en) NUCLEOSIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
JPS60192767A (en) Phenolsulfonephthaleinyl-beta-d-ga;actoside, manufacture anddiagnostic agent for detecting beta-d-galactosidase containing same
Knaggs et al. New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT)
JPH0262890A (en) Polyacetyloligosaccharide derivative
WO2001044228A2 (en) Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
EP0342599A2 (en) Polyacetyl oligosaccharide derivatives
US4257939A (en) Peptide derivative
JPS63316743A (en) Deacylation process
CA1285936C (en) 3-acylamino-3-deoxyallose derivatives
JP2663105B2 (en) 14α-hydroxy-4-androstene-3,6,17-trione hydrate crystal and method for producing the same
JPH01311094A (en) Polyacetyl oligosaccharide derivative
FR2875803A1 (en) PREPARATION OF PHENOL-AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES
WO2000063170A1 (en) Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase 5
JP2976017B2 (en) Double-headed nucleobase derivatives cross-linked with long alkylene chains
JP2000319262A (en) Phenyldiazirine compound and photoaffinity reagent
CA1302406C (en) Method of manufacturing moranoline derivatives
JPS5830316B2 (en) 1-thikane-1H-tetrazole-5-thiolinoseizouhou
JPH0381258A (en) New dopa derivative
JPS58172399A (en) Muramyl tripeptide derivative
JPS5919555B2 (en) Nitrosourea transparent conductor and its manufacturing method
JPH06199808A (en) Production of 5-cyclohexylmethylhydantoin derivative and intermediate for production thereof
CN116903489A (en) Terphenyl compound, preparation method and application thereof
JPH0249796A (en) Polyacetyloligosaccharide derivative
JPH0149277B2 (en)
JPS5935918B2 (en) organic germanium compounds

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees